CIK 0000732712
- Large accelerated filer
VERIZON COMMUNICATIONS INC
Sign in to watch- Ticker
- VZ
- Exchange
- NYSE
- Industry
- Telephone Communications (No Radiotelephone)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 232259884
- Phone
- +1 212-395-1000
- Business address
- 1095 AVENUE OF THE AMERICAS, NEW YORK, NY, 10036
- Former names
- BELL ATLANTIC CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $669,790
- in 13 filings, $670K under 10b5-1 plans
Net −$669,790. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-19 | Malady Kyle EVP and Group CEO-VZ Business | Grant or award · Phantom Stock (unitized) | +133.07 | $13.06 | $2K | 431,647.25 |
| 2026-11-17 | Malady Kyle EVP and Group CEO-VZ Business | Sale 10b5-1 | −1,100 | $46.06 | $51K | 95,566 |
| 2026-11-10 | Malady Kyle EVP and Group CEO-VZ Business | Sale 10b5-1 | −1,100 | $46.11 | $51K | 96,666 |
| 2026-11-05 | Malady Kyle EVP and Group CEO-VZ Business | Grant or award · Phantom Stock (unitized) | +131.98 | $13.17 | $2K | 431,514.19 |
| 2026-11-03 | Malady Kyle EVP and Group CEO-VZ Business | Sale 10b5-1 | −1,100 | $44.79 | $49K | 97,766 |
| 2026-10-27 | Malady Kyle EVP and Group CEO-VZ Business | Sale 10b5-1 | −1,100 | $43.00 | $47K | 98,866 |
| 2026-10-22 | Malady Kyle EVP and Group CEO-VZ Business | Grant or award · Phantom Stock (unitized) | +134.66 | $12.91 | $2K | 424,778.38 |
| 2026-10-20 | Malady Kyle EVP and Group CEO-VZ Business | Sale 10b5-1 | −1,100 | $44.48 | $49K | 99,966 |
| 2026-10-13 | Malady Kyle EVP and Group CEO-VZ Business | Sale 10b5-1 | −1,100 | $42.93 | $47K | 101,066 |
| 2026-10-08 | Malady Kyle EVP and Group CEO-VZ Business | Grant or award · Phantom Stock (unitized) | +131.36 | $13.23 | $2K | 424,643.72 |
| 2026-10-06 | Malady Kyle EVP and Group CEO-VZ Business | Sale 10b5-1 | −1,100 | $45.75 | $50K | 102,166 |
| 2026-09-29 | Malady Kyle EVP and Group CEO-VZ Business | Sale 10b5-1 | −1,100 | $46.40 | $51K | 103,266 |
| 2026-09-24 | Malady Kyle EVP and Group CEO-VZ Business | Grant or award · Phantom Stock (unitized) | +128.7 | $13.51 | $2K | 424,512.36 |
| 2026-09-22 | Malady Kyle EVP and Group CEO-VZ Business | Sale 10b5-1 | −1,100 | $47.65 | $52K | 104,366 |
| 2026-09-15 | Malady Kyle EVP and Group CEO-VZ Business | Sale 10b5-1 | −1,100 | $51.19 | $56K | 105,466 |
| 2026-09-10 | Malady Kyle EVP and Group CEO-VZ Business | Grant or award · Phantom Stock (unitized) | +121.91 | $14.26 | $2K | 424,383.66 |
| 2026-09-08 | Malady Kyle EVP and Group CEO-VZ Business | Sale 10b5-1 | −1,100 | $49.98 | $55K | 106,566 |
| 2026-09-01 | Malady Kyle EVP and Group CEO-VZ Business | Sale 10b5-1 | −1,100 | $50.50 | $56K | 107,666 |
| 2026-08-27 | Malady Kyle EVP and Group CEO-VZ Business | Grant or award · Phantom Stock (unitized) | +123.24 | $14.11 | $2K | 424,261.75 |
| 2026-08-25 | Malady Kyle EVP and Group CEO-VZ Business | Sale 10b5-1 | −1,100 | $50.06 | $55K | 108,766 |
Page 1 of 4 · 75 trades